Paclitaxel study for short anterior urethral narrowing
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether paclitaxel can help treat a short narrowing (stricture) in the front part of the urethra. You might be considered if your symptoms and urine flow match specific cutoffs and if you have not had prior treatment for this problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a narrowing (stricture) in the front part of the urethra (anterior urethral stricture).
- Your stricture is short—less than 2 centimeters.
- Your prostate symptom score is below 11 (from the IPSS questionnaire).
- Your maximum urine flow rate is under 15 mL per second.
- You have not had any previous treatment for urethral stricture.
- This is not a repeat (recurrent) stricture case.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug-coated balloon to treat a narrowing in the urethra (the tube that carries urine out of the body) that has not been treated before. The balloon releases a medication to help keep the area open.
This trial tests if a balloon coated with a drug (paclitaxel) helps prevent the urethra from narrowing again after treatment. It may be an option for people whose stricture has come back after a prior procedure.
This Phase 4 study checks how well a urethral treatment (Optilume) works for a specific type of urethral narrowing, and whether it affects semen (sperm) quality. You may be a fit if you have an anterior urethral stricture and your baseline semen numbers are above required thresholds.
This trial tests a special balloon called Optilume that widens a blocked ureter (the tube from your kidney to bladder) and releases medication to help keep it open. It might be an option if you have a single, short ureter narrowing and your kidneys are working well.
This trial studies a medicine-coated balloon (paclitaxel) placed during endoscopy to keep a non-cancer bowel narrowing (stricture) open longer. It may help reduce repeat procedures if standard balloon dilation hasn’t worked well enough.
This study is testing a new ultrasound measurement called the Urethral Resistive Index (URI) to see if it can accurately diagnose urethral stricture (a narrowing in the tube that carries urine out of the body). The goal is to find a less invasive way to diagnose blockages without needing a scope.
Hear when a new Stricture Urethra trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.